{
    "2018-01-18": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?",
                "features": {
                    "keywords": [
                        "Large-Cap",
                        "Drug Stocks",
                        "Encore"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Merck & Co.’s Business Segments and Performance in 3Q17",
                "features": {
                    "keywords": [
                        "Merck",
                        "Business Segments",
                        "Performance",
                        "3Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label",
                "features": {
                    "keywords": [
                        "Amgen",
                        "FDA",
                        "ENDEAVOR",
                        "Kyprolis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Merck’s & Co.’s Valuation in January 2018",
                "features": {
                    "keywords": [
                        "Merck",
                        "Valuation",
                        "January 2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Market at New Highs: Mega Cap ETFs & Stocks On A Roll",
                "features": {
                    "keywords": [
                        "Market",
                        "New Highs",
                        "Mega Cap ETFs",
                        "Stocks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?",
                "features": {
                    "keywords": [
                        "J&J",
                        "Pharma",
                        "Q4 Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "J&J (JNJ) Hits New 52-Week High: What's Driving the Stock?",
                "features": {
                    "keywords": [
                        "J&J",
                        "52-Week High"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Amgen’s Biosimilars Are Positioned for 2018",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Biosimilars",
                        "Positioned",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "See what the IHS Markit Score report has to say about Johnson & Johnson.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Amgen’s Enbrel and Nplate Are Positioned for 2018",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Enbrel",
                        "Nplate",
                        "Positioned",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's BTG",
                "features": {
                    "keywords": [
                        "U.S. court",
                        "invalidates",
                        "Johnson & Johnson",
                        "cancer drug patent",
                        "BTG"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}